| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |